Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

BIOVERATIV INC. — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

BIOVERATIV INC.

via AVENUE SOLUTIONS

3rd Quarter (July 1 - Sep 30) · 2017Posted Nov 17, 2017Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: BIOVERATIV INC.
Description: Biopharmaceutical development
Location: Massachusetts · United States of America

Registrant

Firm: AVENUE SOLUTIONS
Description: Government representation
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
FDA licensing transfer issue
LobbyistsAMY TEJRAL · TRACY SPICER
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.